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Background: Respiratory irritants represent a major cause of occupational obstructive airway diseases. We provide
an overview of the evidence related to irritative agents causing occupational asthma or occupational COPD.
Methods: We searched MEDLINE via PubMed. Reference lists of relevant reviews were also screened. The SIGN
grading system was used to rate the quality of each study. The modified RCGP three-star system was used to grade
the body of evidence for each irritant agent regarding its causative role in either occupational asthma or
occupational COPD.
Results: A total of 474 relevant papers were identified, covering 188 individual agents, professions or work-sites.
The focus of most of the studies and the predominant diagnosis was occupational asthma, whereas occupational
COPD arose only incidentally.
The highest level assigned using the SIGN grading was 2+ (well-conducted systematic review, cohort or
case–control study with a low risk of confounding or bias). According to the modified RCGP three-star grading, the
strongest evidence of association with an individual agent, profession or work-site (“**”) was found for 17 agents
or work-sites, including benzene-1,2,4-tricarboxylicacid-1,2-anhydride, chlorine, platinum salt, isocyanates, cement
dust, grain dust, animal farming, environmental tobacco smoke, welding fumes or construction work. Phthalic
anhydride, glutaraldehyde, sulphur dioxide, cotton dust, cleaning agents, potrooms, farming (various), foundries
were found to be moderately associated with occupational asthma or occupational COPD (“*[+]”).
Conclusion: This study let us assume that irritant-induced occupational asthma and especially occupational COPD
are considerably underreported. Defining the evidence of the many additional occupational irritants for causing
airway disorders will be the subject of continued studies with implications for diagnostics and preventive measures.
Keywords: Work-related asthma, Occupational asthma, Occupational COPD, RADS, Irritant-induced asthmaIntroduction
Bronchial asthma and chronic obstructive pulmon-
ary disease (COPD) are common conditions and are
the dominating obstructive airway diseases in the
general population.Work-related asthma (WRA) including irritant-induced
occupational asthma (OA)
Occupational asthma is defined as a chronic inflamma-
tory disorder of the airways with recurrent episodes of
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reproduction in any medium, provided the orof breath at rest, and reversible airflow limitations
caused by a particular occupational environment [1-3].
The available epidemiological and comparative studies
and reviews provide evidence that occupational agents
cause 5 – 25% of all asthma cases [1,4-23]. Besides these
evident occupational asthma (OA) cases, there is prob-
ably an even larger population of sufferers of work-
aggravated asthma [24-26]. The latter population shows
an objective worsening of pre-existing asthma or non-
occupational asthma that develops in parallel with
causative conditions encountered in the workplace
(Figure 1).
Occupational agents eliciting bronchial asthma, i.e. OA,
comprise occupational allergens, with their well-defined
etiological role and IgE-mediated pathomechanism, asd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Work-related asthma is divided into occupational
asthma and work-aggravated asthma.









Extremely high, > OEL ≤1 day
Not so sudden onset of
irritant-induced OA
Moderate, around OEL >1 day <4 months
Low dose irritant-
induced OA
Low, below OEL >4 months
OA=Occupational asthma, OEL =Occupational Exposure Limit.
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isms and occupational respiratory irritants, mainly repre-
senting low molecular weight chemicals (LMW; <5000
Daltons) causing irritant-induced OA (Figure 2). The lat-
ter agents may also elicit occupational COPD (see chapter
1.2) and include chlorine, acids, welding fumes, as well as
isocyanates. The etiological role of such low molecular
chemicals has not yet been completely clarified, primarily
because of the lack of specific diagnostic tests.
There is sparse data available on causes and frequen-
cies of irritant-induced COPD and work-aggravated
asthma. Therefore, this work focuses on irritant-induced
OA.
There is increasing evidence that irritant-induced OA
can be further subdivided into three subcategories as
outlined in Table 1 [27-29].
Many case reports, case series and a few cross-
sectional studies demonstrate that a single short-term
accidental massive exposure or several short-term high-
level exposures to a respiratory irritant can cause asthma
within 24 hours without a latency period. Brooks et al.
[30] defined this disorder as “reactive airways dysfunc-
tion syndrome” (RADS). This term was later extended to
irritant-induced OA from multiple, somewhat lower, ex-
posure incidents with a less sudden onset that were also
shown to cause this disorder [27,31-36].Figure 2 Subgroups of OA.Furthermore, there is evidence that a susceptible sub-
group of subjects mainly atopics with non-specific bron-
chial hyperresponsiveness (NSBHR) suffering from
irritant-induced OA, is also affected by chronic expo-
sures to relatively low concentrations of irritant gases,
fumes or aerosols [27,37,38]. This disorder has been
called “low-dose irritant asthma” (or “low-dose RADS”).
Corresponding studies indicate respiratory effects in-
cluding asthma from mainly chronic or repeated expos-
ure to a single irritant or a mixture. Demonstrably
causative concentrations of a particular irritant are often
below their occupational exposure limits (OELs) or per-
missible exposure limits (PELs). Such irritant examples
include swine confinement facilities [39,40], expo-
sures to cleaning agents [12,41], solvents, ozone,
endotoxin, formaldehyde, quaternary ammonium com-
pounds, chlorine, bisulfite and SO2, or acid mist
[36,37,42-44], diesel exhaust [10,45,46], fumigant resi-
dues [47], dusts in the textile paper, mineral fiber or
construction industries or in mines [48-51], as well as a
proportion of cases of potroom asthma [52] and meat-
wrappers’ asthma [53]. Asthma in cold-air athletes may
also be relevant [54,55]. A previous summary of the lit-
erature on respiratory effects from asthma due to irri-
tants below their OELs/PELs is available [56]. Many of
the earlier exposure limits have been lowered repeatedly
in the light of subsequent clinical or epidemiological
findings on their respiratory effects. Other limits remain
obstinately high given their known irritative effects and/
or that they are based on sparse data [56]. Accordingly,
adherence to OELs/PELs does not preclude the onset of
WRA in susceptible subjects.
The broader definition of these disorders (as used in
the legal definition in Germany) includes all irritant-
induced obstructive airway diseases irrespective of their
causative concentrations and reversibility, i.e. irritant-
induced occupational asthma as well as COPD.
Frequency of OA
OA has become the most prevalent occupational lung
disease in developed countries [57,58] and it is one of
the most frequent diagnosis among occupational dis-
eases in general [59]. The annual incidence of OA is in
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million workers and more than 1,300 per million in spe-
cific workplaces [57,60]. As already mentioned there is
evidence that occupational agents cause 5 - 25% of of all
asthma cases. However, complete registries of OA do
not exist and therefore the true frequency of the disease
is unknown. Ameille et al. [61] and Fernández-Nieto
et al. [59] stated that OA is underestimated among occu-
pational diseases, because many OA cases are not sub-
jected to appropriate diagnostic tests.
Irritant-induced OA is reported to occur in approxi-
mately 5 -18% of all OA cases, being the second most
common form of OA after allergic OA [36,62].Chronic obstructive pulmonary disease (COPD) due to
occupational exposure
The diagnosis of COPD is based on chronic productive
cough, airflow limitation that is usually not fully revers-
ible, and a progressive, abnormal inflammative response
of the lungs mostly caused by long-term smoking and by
other noxious particles or gases [1].
During ongoing causative exposures (e.g. smoking par-
ticles, droplets and/or gases), airflow limitation is usually
progressive and associated with an abnormal inflamma-
tory response of the lungs. Patients with COPD have
greater number of neutrophils and alveolar macrophages
in bronchoalveolar lavage fluid than healthy non-
smokers [63]. Sites of emphysema, which are frequently
found in COPD patients, contain large numbers of lym-
phocytes, and the extent of lymphocyte accumulation
correlates with reduction of FEV1.
In their summaries of the literature, Hnizdo et al. [64],
Trupin et al. [65] and Balmes et al. [1] found an occupa-
tional contribution in about 15% of COPD cases.
Occupational COPD is identified on epidemiological
basis, by observing increased frequencies of COPD
among certain working groups [66], e.g. in construction
workers [2]. Some occupational exposures (e.g. welding
fumes, aluminium, potroom fumes, and cadmium) may
cause COPD associated with emphysema [67,68].
At later stages of OA, the condition of some subjects
does not improve over weekends or during holidays and
coincides with symptoms of COPD patients. This obser-
vation also applies to non-occupational obstructive air-
ways diseases [69,70] and indicates that a group with
changing diagnoses as well as with some overlap between
OA and occupational COPD, does exist [66,71-73].Background and objective
WRA and occupational COPD are serious and some-
times fatal diseases, which can lead to ill health, inability
to work and lost productivity [1,25,74-76]. They repre-
sent a huge economic burden to the society. For detailssee Additional file 1: Online Supplement “Economic
burden”.
The objective of this study is to summarize present
knowledge on respiratory irritants causing obstructive
airway diseases in humans in the occupational setting
and to provide a rating of the strength of evidence for
each irritant which has not been previously available.
Methodology
A systematic review of the literature on occupational
irritant-induced OA and occupational COPD due to oc-
cupational irritants was conducted. We considered
asthma-inducing irritating agents as well as those
reported to cause occupational COPD and related disor-
ders, where obstructive ventilation patterns were
demonstrated in clinical investigations, cross-sectional
studies, cross-shift and/or in long-term exposure studies.
Irritating gases mainly occurring in the general environ-
ment, such as ozone, and inorganic dusts, including sil-
ica, talcum, silicates and other fibers known to cause
pneumoconioses, were not considered even though ex-
posure to them is frequently associated with mixed ven-
tilation patterns.
Definitions used
Occupational COPD: chronic bronchitis symptoms and
non-reversible airflow limitation due to particular occu-
pational environment (if lung function data was avail-
able; otherwise, clinical diagnosis as given by the authors
is cited).
Occupational asthma: episodes of shorteness of breath
due to particular occupational environment and revers-
ible airflow limitation (if lung function data was avail-
able; otherwise, clinical diagnosis as given by the authors
is cited).
Obstructive ventilation pattern: we applied reference
values of FEV1/FVC from Brändli, Schindler et al. 2000
[77].
Information sources and selection criteria
Occupational respiratory irritants
To identify the evidence of irritants of the respiratory
tract, all agents denoted as “may cause respiratory irrita-
tion” by the phrase H335 (previous code R37) and “may
cause allergy or asthma symptoms or breathing difficul-
ties if inhaled” H334 (previous code R42) [78] and/or as
“irritants” by American Conference of Governmental In-
dustrial Hygienists [79] were initially listed [80]; later
this list was compared with results of our database
search (see below).
Database search.
We searched for publications reporting investigations
exclusively in humans (i.e. animal or in-vitro research
was excluded). To be included, the publications had to
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irritants.
MEDLINEW-Database was searched with PubMedW
from its inception up to December 2007 with the follow-
ing medical subject headings (MeSH) combinations for
each single agent:
“Agent”[MeSH] AND “Humans”[MeSH] AND
((“Asthma”[MeSH] OR “Asthma/chemically
induced”[MeSH] OR “Asthma/immunology”[MeSH])
OR “Pulmonary Disease, Chronic Obstructive”[MeSH]
OR “Lung Diseases, Obstructive/*chemically
induced”[MeSH] OR “Respiratory Function
Tests”[MeSH]) AND (“Accidents,
Occupational”[MeSH] OR “Occupational
Exposure”[MeSH] OR “Occupational Diseases”[MeSH]
OR “Occupational Diseases/chemically
induced”[MeSH])).
If more than 20 publications per agent were found, the
search was more specified:
“Agent”[MeSH] AND “Humans”[MeSH] AND (“Cohort
Studies”[MeSH] OR “Case–control Studies”[MeSH] OR
“Case–control Studies”[All Fields] OR “Longitudinal
Studies”[MeSH] OR “Longitudinal Studies”[All Fields]
OR “Cross-Sectional Studies”[MeSH] OR “Cross-
Sectional Studies”[All Fields] OR “Epidemiologic
Studies”[MeSH] OR “Epidemiologic Studies”[All Fields]
OR “Case Reports”[Publication Type] OR “Meta-
Analysis”[MeSH] OR “Meta-Analysis”[All Fields]) AND
“adverse effects”[Subheading] AND ((“Asthma”[MeSH]
OR “Asthma/chemically induced”[MeSH] OR “Asthma/
immunology”[MeSH]) OR “Pulmonary Disease,
Chronic Obstructive”[MeSH] OR “Lung Diseases,
Obstructive/*chemically induced”[MeSH] OR
“Respiratory Function Tests”[MeSH]) AND
(“Accidents, Occupational”[MeSH] OR “Occupational
Exposure”[MeSH] OR “Occupational Diseases”[MeSH]
OR “Occupational Diseases/chemically
induced”[MeSH])).Reference list screening
We also considered references in the identified already
existing 13 systematic reviews or overviews of causes of
work-related asthma or COPD and tried to combine
results of both approaches.Occupational diseases statistics
Further, we considered the following occupational dis-
eases statistics based either on statutory surveillance or
registration systems: SWORD 1994–1997 [81-83];
SHIELD 1993 [74]; SORDSA 2001 [84]; SENSOR 2003[85]; Dokumentation der Berufskrankheiten 2007 (BK-
DOK) [86].Conditions
Four different conditions were accepted for inclusion:
1. Irritant-induced OA including RADS. Asthma
caused by single or multiple occupational exposures
to airway irritants; de novo irritant-induced OA.
Asthma within 24 hours without a latency period
caused by short-term high-level exposures to a
respiratory irritant known as acute irritant-induced
asthma, or as RADS [30].
2. Work-aggravated (exacerbated) irritant-induced OA.
Pre-existing or concurrent asthma worsened by
work factors [24]. Subjects with work-related
asthmatic symptoms, if not differentiated whether
new-onset or work-aggravated.
3. Occupational COPD. On epidemiological basis,
identified by observing increased frequencies of
COPD among certain working groups [66].
4. Obstructive ventilation pattern. Studies about
irritant agents, where obstructive ventilation
patterns in occupational settings were reported.Methodological selection criteria
Publications with one of the following study designs
were included: Systematic reviews of cohorts, case–con-
trol or cross-sectional studies, cohort studies (prospect-
ive/retrospective), case–control studies, cross-sectional
studies, surveys.
Non-analytic1a studies (i.e. case series, follow-up of
cases or case reports) were only included when for an
agent no studies with one of the above mentioned
designs had been identified.
Publications were included when they met any of the
following criteria: examining the frequency of irritant-
induced OA or asthmatic work-related symptoms in oc-
cupationally exposed groups or individuals, reporting
the causative role of the specific agent or mixture of
agents for irritant-inducing WRA or COPD.
Studies were included when they applied any of the
following diagnostic tools: description of work-related
asthmatic symptoms (questionnaire), lung function test
(LFT), testing for non-specific bronchial hyperrespon-
siveness (NSBHR) by means of methacholine, histamine
or other pharmacological agents, serial spirometry or ex-
piratory peak flow (PEF) monitoring or supervised ex-
posure testing in the workplace, challenge with the help
of lung function measurements (SFT), specific inhalation
challenge testing (SIC), clinical diagnosis of OA by an
expert (occupational or pulmonary physician), and ex-
posure to an irritant agent.
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Methodological studies, e.g. on effects of study design
and subsequent procedures, and studies with non-
occupational disorders were excluded. Publications
about occupational agents which do not have an irritant
effect on the respiratory tract (e.g. about IgE-sensitizing
agents) or with unrelated issues (e.g. studies on im-
munological questions) were also excluded.Assessment of study quality
The principal study characteristics and study results
were systematically extracted using an extraction sheet
(see Additional file 2: Table S1A of online supplement
“Methodology”).
We assessed study quality with the help of a check list
(see Additional file 2: Table S1B of online supplement
“Methodology”). The evidence level of each study was
graded according to the revised Scottish Intercollegiate
Guidelines Network (SIGN) grading system [87]. Since
population-based randomized assignment to different
levels of irritant exposure are unethical, no randomised
controlled trials (RCTs) could be expected on this topic
and, thus, no level 1 evidence (as defined by the revised
SIGN grading system) [87] would be available. In order
to achieve more differentiation among lower evidence
grades, we modified the SIGN grading system and added
an additional grade (3+) (see Additional file 2: Table S1C
of online supplement “Methodology”).
Details of the modified RCGP [88] grading system are
given in the online supplement “Methodology”, Add-
itional file 2: Table S1D.Results
Overview on publications retrieved
The database search (MEDLINE/ PubMed) yielded 383
potentially relevant publications. 480 additional poten-
tially relevant publications were retrieved from the refer-
ence lists of 13 systematic reviews or overviews
[2,30,36,80,89-97], from occupational diseases routine
statistics (SWORD 1994–1997 [47,81-83]; SHIELD 1993
[74]; SORDSA 2001 [84]; SENSOR 2003 [85]; BK-DOK
2007 [86], and from the library of the Institute of Occu-
pational Medicine, Hamburg. Alltogether, the different
search approaches yielded a total of 474 relevant studies,
including an extreme early study from the year 1932
[98]. (See selection flow diagram, Figure 3).
Most (n = 337) of the 474 relevant publications were
identified through hand searching (i.e. reference list
checking of systematic reviews and from our library
database).The 474 publications refer to 131 individual agents, 46
to “mixed” agents and 11 to work-sites or professions
reported to cause OA and/ or occupational COPD.Diagnostic aspects
Many different ways of confirming irritant-induced OA
were used, with specific inhalation challenge (SIC) and
lung function tests (LFT) being the most reliable diag-
nostic aids.
SIC was used as the “gold standard” in confirming OA
mainly in non-analytical studies (n = 189 studies, i.e. 72%
of non-analytical studies). Only few (n = 16, i.e. 7.5% of
analytical studies) cohort or case–control reported diag-
nostic confirmation with SIC.
Another frequently used (n = 191) diagnostic method
for OA or occupational COPD was lung function testing
(LFT); showing an obstructive ventilation pattern and/or
NSBHR related to occupational exposures, mostly in
combination with WRA symptoms.
Exclusively self-reported asthma symptoms or phys-
ician reported asthma as documented in questionnaires
as an alternative diagnosis for OA was used in 36
studies.
Other studies (n = 44) had not clear diagnosis of OA
or occupational COPD but reported obstructive ventila-
tion pattern. The number of subjects with asthma
symptoms and frequencies of obstructive ventilation
patterns and/or NSBHR are provided for each study
(see Additional file 3: Table S2E of online supplement
“Results”).Irritant-induced OA as outcome
Irritant-induced OA was the focus of most studies and
was the predominant diagnosis.
RADS, as a subgroup of irritant-induced OA, was
reported to be due to 47 different agents, with the most
prevalent being the World Trade Center disaster in 2001
(n = 7 studies), chlorine (n = 11), cleaning agents (n = 18)
and isocyanates (n = 46). These were followed by disor-
ders, caused by metam sodium (n = 17), ammonia
(n = 11), diesel exhaust (n = 10), acids (n = 9), solvents
(n = 8), sulfur dioxide (n = 7), dinitrogen tetraoxide
(n = 6), hydrogen chloride (n = 4), smoke (fires, pyrolysis
products) (n = 4), chlorofluorocarbons (n = 4), spray
paint (n = 3), tear gas (n = 3), bromine (n = 2), dichlorvos
(n = 2), sodium azide (n = 2), acrylates (n = 1), amprolium
hydrochloride (n = 1), phthalic anhydride (n = 1), bromo-
chlorodifluoromethane (n = 1), bromotrifluoromethane
(n = 1), chloramine T (n = 1), chromate (n = 1), hydrazine
(n = 1), hydrogen fluoride (n = 1), methylmercaptan
(n = 1), phosgene (n = 1), uranium hexafluoride (n = 1),
airbag content (n = 1), bleaching agent (n = 1), floor seal-
ant (n = 1), fumigant (n = 1), metal coat remover (n = 1),
Figure 3 Flow diagram demonstrating the source of references.





number of studies (n)
○ ammonia (1)
○ cement dust (4)
○ chlorine (1)
○ cleaning agent (1)
○ mustard gas (1)
○ diesel exhaust (2)
○ environmental tobacco smoke(1)
○ isocyanate (1)
○ smoke (1)
○ sulphur dioxide (1)
○ construction work (3)
○ swine confinement (1)
○ farming (1)
○ foundry (1)
○ metallurgical industry workers (1)
COPD=Chronic obstructive pulmonary disease.
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ceramic fibers (n = 1), swine confinement (n = 1).
The majority of asthma-inducing agents elicited OA
after prolonged exposure and rarely after a single
exposure.
Work-aggravated asthma was of less importance in the
literature and occurred in only a few studies [30,99-104].
Occupational COPD as outcome
Ten agents and five professions or work-sites were
reported to cause occupational COPD, as shown in
Table 2.
As already mentioned, occupational COPD was not
specifically addressed in most of the studies. Some de-
scribe respiratory symptoms, such as chronic bronchitis
(n = 21), which may be indicative of COPD. One of the
few studies which specifically focused on COPD, was a
large retrospective cohort study on diesel exhaust whichcaused a significantly increased COPD mortality in rail-
road workers after the introduction of diesel engines in
1945 [105,106]. Construction work was identified as a
cause of occupational COPD in 2 publications [8,107].
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Some publications investigated more than one irritant
agent and thus have been considered several times in
our study.
262 of the 474 publications were non-analytic studies
and were rated according to SIGN as 4, 3 or 3+ and con-
sisted of case reports (n = 228), case series (n = 63), and
occupational diseases statistics (n = 33) and reviews of
that kind of studies (n = 7). The other publications
reported analytical studies and were rated according to
SIGN as 2+ (n = 15), 2- (n = 103), or 3+ (n = 83).
The highest level was 2+, indicating a well conducted
analytical study (case control or cohort studies) with a
low risk of confounding or bias (n = 15 studies). Other
studies with a similar design had a higher risk of con-
founding or bias and were individually rated lower by
SIGN grading of 2- (n = 30 studies). Most of the other
analytical studies were rated with a SIGN grade of 2-,
because their design (cross-sectional or longitudinal
study) was limiting (n = 82 studies). Cross-sectional stud-
ies or longitudinal studies, e.g. those with high risk of
confounding or bias, were rated even lower with 3/ 3+
(n = 35 studies). A couple of study designs were difficult
to classify epidemiologically, including those which were
surveys, mostly with very low analytical evidence, rated
3/ 3+ (n = 53 studies), or larger surveys with a lower risk
of confounding or bias, which were graded with 2- (n = 4
studies).
Investigations involving dose–response relationship as
a form of scientific evidence were performed in 30 out
of 474 studies analyzed [68,105,106,108-133].
Another assessment of the level of evidence found
in individual studies is to consider their OR for
irritant-induced OA or occupational COPD; this was
done in 39 publications [15,23,44,48,105-108,113,117-
120,122,126,128,134-156].
Strength of evidence per agent, work-site or profession
The outcome for each agent causing OA or occupational
COPD was graded according to the modified RCGP
three-star system to classify the strength of evidence of
its causative role in irritant-induced OA/ occupational
COPD. The strongest evidence achieved was two stars
“**” (indicating a moderate strength of evidence provided
by generally consistent findings in fewer, smaller or
lower quality scientific studies) for 17 (mixed) agents,
work-sites or professions. For six of them (chlorine, plat-
inum salts, environmental tobacco smoke, welding
fumes, construction work, World Trade Center disas-
ter in 2001), this level was based on well- conducted
studies with low risk of confounding and/or bias
(SIGN 2+). For eleven of these 17 (mixed) agents, SIGN
levels of individual studies were lower (benzene-1, 2, 4-
tricarboxylic acid-1,2-anhydride [trimellitic anhydride],cobalt, isocyanates, cement dust, grain dust, animal
farming (pig, beef/veal, dairy, poultry), or swine
confinement.
Low to moderate scientific evidence – provided by
generally consistent findings in fewer, smaller or lower
quality analytical studies, based on questionnaires or
other inadequacies, i.e. “*[*]” – was found for 12 agents
(phthalic anhydride, glutaraldehyde [glutaral], sulfur di-
oxide, cotton (dust, raw) CNT 750, potroom aluminum
smelting, farming (various) or foundry), smoke (fires,
pyrolysis products), pesticides (not specified), cleaning
agents (not specified), ceramic production (dust), health
care workers.
Limited or contradictory evidence – provided by only
one analytical study or inconsistent findings in multiple
scientific studies, i.e.“*” – was identified for 39 agents,
and after down-grading because of inadequate methodo-
logical aspects, i.e. “[*]” on three occasions. For the ma-
jority of agents, only non-analytical studies were
reported for ≥ 5 cases, i.e. “(*)” or less than 5 cases, i.e.
“-”. When only non-analytical studies were available, the
strength of evidence for the agent was raised if at least 5
cases were identified by the case reports/ case series or
occupational disease statistics for which proof of
irritant-induced OA or occupational COPD existed. The
strength of evidence reached when only non-analytical
studies were available ranged from “very limited or
contradictory evidence” in 29 studies, i.e. “(*)”, to “no
scientific evidence” “-” 94 times. (see Tables 3 and 4 and
Additional file 3: Table S2E of online supplement
“Result”).
The compiled assessment of the individual studies,
along with their relevant clinical data and strength of
evidence for irritant agents, professions or workplaces
causing asthma or COPD, is presented as a summary list
(see Additional file 3: Table S2E “Results” for the full
information).Discussion
The main objective of this study was to give a compre-
hensive and evidence-based overview of the literature on
irritative agents, professions or work-sites causing
irritant-induced work-related asthma and occupational
COPD. To our knowledge this study is the first attempts
to document these respiratory disorders, along with their
causative irritant agents in an evidence-based manner.
The 474 publications retrieved (see Table 3 and Add-
itional file 3: Table S2E of online supplement “Results”)
in this work mainly refer to individual agents (n = 131),
but also to mixed exposure(s) or multicomponent work-
sites or professions (n = 57) where heterogeneous expos-
ure to irritating substances is common, e.g. swine con-
finement, “construction work” or “farming”, giving 188
Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD
Agent CAS Strength of evidence





", acetic * 3 [108,157,158]
64-19-7
", not specified (*) 2 [30,37]
", dodecanedioic - 1 [159]
693-23-2-1
", various - 1 [35]
", " (hydrochloric, hydrofluoric, nitric, perchloric, sulfuric) - 1 [160]
", hydrochloric (*) 6 [35,99,161,162]
7647-01-0
", hydrofluoric - 1 [163]
7664-39-3
", sulfuric * 3 [99,109,164]
7664-93-9
Acrylates
", not specified - 1 [165]
", alkyl cyanoacrylates (*) 4 [166-169]
", cyanoacrylate glue - 1 [170]
", " [loctite] * 4 [44,169,171,172]
53858-53-0
", methacrylates * 1 [134]
", methyl 2-cyanoacrylate - 3 [166,169,173]
137-05-3
", methylmethacrylate - 2 [169,174]
80-62-6
Aluminum salts * 1 [100]
aluminum fluoride: 7724-18-1
aluminum sulfate: 10043-01-3
2-Aminoethanol [2-ethanolamine] - 1 [175]
141-43-5
Amino-ethyl-ethanolamine - 1 [176]
111-41-1
3-Amino-5-mercapto-1,2,4-triazole (*) 1 [177]
16691-43-3
Ammonia * 6 [41,178-182]
7664-41-7
Ammonium chloride (triple salt) - 1 [183]
12125-02-9
Ammonium thioglycolate - 1 [184]
5421-46-5
Amprolium hydrochloride - 1 [185]
137-88-2
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Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD (Continued)
Anhydrides
", various * 2 [186,187]
", dioctyl phthalate - 1 [188]
117-81-7
", hexahydrophthalic - 1 [189]
37226-48-5
", himic - 1 [190]
2746-19-2
", maleic - 2 [191,192]
108-31-6
", methyltetrahydrophthalic - 1 [193]
26590-20-9
", phthalic anhydride *[*] 5 [194-198]
85-44-9
", pyromellitic dianhydride - 1 [199]
89-32-7
", tetrachlorophthalic anhydride * 4 [200], [201], [202],
[203]117-08-8




Aziridine, polyfunctional (*) 2 [208,209]
64265-57-2
Azobisformamide [azodicarbonamide] * 5 [210-214]
123-77-3
Benzalkonium chloride (fumes) - 2 [215,216]
8001-54-5
1, 2-Benzisothiazoline-3-one (fumes) - 1 [217]
2634-33-5
Bisulfite, SO2 - 1 [37]
SO2: 7446-09-5
Bromine, hydrobromic acid - 1 [218]
Bromochlorodifluoromethane (Halon 1211) - 1 [101]
353-59-3
Bromotrifluoromethane (Halon 1301) - 1 [219]
75-63-8
Cadmium (fumes) * 4 [68,220-222]
7440-43-9
Calcium carbonate [chalk powder] - 1 [110]
Calcium oxide - 1 [35]
1305-78-8
Captafol (chlorinated thiocarboximide fungicide) - 1 [223]
2425-06-1
Carbon black dust * 1 [224]
1333-86-4
Chloramine T (powder dust) (*) 5 [225-229]
7080-50-4
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Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD (Continued)
Chlorhexidine - 1 [230]
55-56-1
Chlorine ** 11 [35,165,231-239]
7782-50-5
Chromate (not specified) (*) 9 [240,241]
[98,242-247][see also cement]






Diamine, aliphatic + cycloaliphatic (hardener) 2855-13-2
(isophorone diamine)
- 1 [261]
Diazonium tetrafluoroborate 14239-22-6 - 2 [262,263]
Dichlorodiethyl sulfide [mustard gas] +505-60-2 (*) 1 [264]
Dichlorvos (organophosphate) - 2 [265,266]
62-73-7
Diethanolamine - 1 [267]
111-42-2
2-Diethylaminoethanol [diethyl aminoethanol] (*) 1 [268]
100-37-8
2-Dimethylaminoethanol [dimethyl ethanolamine] - 2 [269,270]
108-01-0
Diinitrogen tetraoxide [dinitrogentetroxide] (*) 1 [271]
10544-72-6
Ethylenediamine [ethylene diamine] * 6 [168,184,272-275]
107-15-3
Ethylene oxide - 2 [276,277]
75-21-8
Formaldehyde (gas, dust) * 9 [278-283],
[284,285]50-00-0
Freon, (freon-22) - 2 [286,287]
Glutaraldehyde [glutaral] *[*] 9 [74,83,288-294]
11-30-8
Hexachlorophene - 1 [295]
70-30-4
Hexamethylenetetramine * 3 [184,296,297]
100-97-0
Hydrazine - 1 [30]
302-01-2
Iridium salt - 1 [298]
Isocyanates, isocyanurate
", various (HDI, MDI, TDI) ** 11 [57,83,148,149,
165,281,299-303]
", Diphenylmethane diisocyanate [MDI] ** 7 [304-310]
5873-54-1
", " prepolymers - 1 [311]
", Hexamethylene diisocyanate [HDI]; plus isodurane
Diisocyanate
(*) 3 [312,313]
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Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD (Continued)
822-06-0






", Methyl isocyanate [MIC] * 6 [316-321]
624-83-9
", 1,5-Naphthylene diisocyanate [NDI] (*) [46] [322-324]
3173-72-6
", Polymethylene polyphenyl isocyanate * 1 [325]
9016-87-9
", Toluene diisocyanate, TDI 2,4: 584-84-9; ** 12 [35,125,165,
326-334]2,6:91-08-7
", Triglycidil isocyanurate - 1 [335]
2451-62-1
", Triphenylmethane triisocyanate - 1 [336]
Isothiazolinone - 1 [337]
55965-84-9
Lauryl dimethyl benzyl ammonium chloride - 1 [338]
139-07-1
Metam sodium [methyldithiocarbamate] - 1 [102]
144-54-7
Methylmercaptan - 1 [165]
74-93-1
Monoethanolamine - 1 [184]
141-43-5
N-methylmorpholine [*] 1 [339]
109-02-4
Nickel sulphate (*) 5 [246,340-343]
!anhydrous 7786-81-4
!hexahydrate 10101-97-0
Ninhydrin 485-47-2 - 1 [335]
Nitrogen chloride [nitrogen trichloride, trichloramine] [*] 2 [150,344]
10025-85-1
Ozone (gassings) * 1 [345]
10028-15-6
Palladium - 1 [346]
7440-05-3
Paraphenylenediamine (*) 1 [347]
106-50-3
Paraquat * 2 [128,151]
4685-14-7
Persulfate
", not specified (*) 2 [348,349]
", ammonium - 1 [350]
", potassium (7727-21-1) and ammonium peroxydisufate [*] 5 [351]
(7727-54-0)
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Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD (Continued)
", alcalic - 1 [352]
", Sodium persulfate - 1 [353]
7775-27-1
", Dipotassium peroxo-peroxodisulfate [potassium
persulfate] 7727-21-1
- 1 [354]
", Diammonium peroxodisulfate [ammonium persulfate] * 4 [355-357]
7727-54-0
Phenylglycine acid chloride * 1 [358]
39478-47-2
Phosgene - 2 [35,359]
75-44-5
Piperazine dihydrochloride * 3 [130,176,274]
142-64-3
Platinum salts ** 8 [131,176,360-365]
(7440-06-4)
Polyethylene - 3 [366-368]
9002-88-4
Polymethyl-methacrylate [plexiglas powder] - 1 [369]
9011-14-7
Polypropylene, heated to 250 °C [*] 2 [370,371]
9003-07-0
Polyvinyl chloride (fume) * 8 [53,372-376]
[377,378]9002-86-2
Potassium dichromate (*) 1 [379]
7778-50-9 ( see also chromium;cement)
Potassium aluminum tetrafluoride (*) 1 [380]
14484-69-6
Rosin core solder, thermal decomposition [colophony] * 6 [74,83,381-383]
8050-09-7
Sodium azide (powder dust) - 1 [384]
26628-22-8
Sodium iso-nonanoyl oxybenzene sulphonate
[SINOS] 123354-92-7
(*) 3 [385-387]
Sodium metabisulfite [metabisulfite sodium] (*) 6 [103,388-392]
7681-57-4
Styrene monomer (*) 3 [132,393,394]
100-42-5
Sulfur dioxide *[*] 5 [35,154,395-397]
7446-09-5
Sulfathiazole - 1 [398]
72-14-0
Terpene (3-carene) - 2 [399,400]
13466-78-9
Tetrachloroisophthalonitrile (fungicide) - 1 [401]





Tributyl tin oxide [carpet fungicide] - 1 [404]
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Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD (Continued)
Triethanolamine - 1 [175]
102-71-6
Tungsten carbide - 1 [405]
11130-73-7
Tylosin tartrate - 1 [406]
Uranium hexafluoride - 2 [30,407]
7783-81-5
Urea (fume) - 1 [104]
57-13-6




Vanadium 7440-62-2+divanadium pentoxide * 5 [84,409-412]
1314-62-1
Zinc (fume) - 3 [413-415]
7440-66-6
Zinc chloride (fume) - 1 [183]
7646-85-7
Mixed agent Evidence level Number of studies
per agent
Acid fluxes - 1 [74]
Acrylic acid - 1 [166]
Airbag content - 1 [416]
Bleaching agent (fumes) - 1 [99]
Cement ** 14 [111,133,235,
417-427]65997-15-1
Chlorofluorocarbons (*) 2 [428,429]
(degradation products)
Cleaning agents (not specified) *[*] 9 [15,37,41,112,
135,430-433]
", detergents - 2 [434,435]
Coffee, green * 5 [436-440]
Cotton (dust, raw) *[*] (12) [48,114-116,423,
441-447]CNT 750
Cutting oil - 2 [37,448]
Diesel exhaust * 5 [10,45,46,105,106]
ECG ink - 2 [449,450]
Endotoxin (see also cotton dust, swine confinement,
poultry confinement, house dust)
* 2 [41,451]
Environmental tobacco smoke ** 10 [117,118,138-143,
452,453]
Floor sealant (aromatic hydrocarbons) - 1 [30]
Fumigating agent - 1 [30]
Furan-based binder - 1 [454]
Grain ** 9 [48,122-124,
455-459]
", rice [*] 1 [460]
Hairdressing chemicals (*) 1 [281]
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Table 3 Overview of individual agents causing irritant-induced OA or occupational COPD (Continued)
Lubricants (not specified) (*) 2 [10,57]
Metal coat remover (coating removing chemical) - 1 [30]
Metal oxide (fume) - 1 [461]
Metal working fluids [MWF] - 1 [462]
Oil (spill) * 1 [126]
Paint (fumes) * 4 [35,127,463,464]
Paper dust A111 (*) 1 [48]
Perfume agents (research lab) - 1 [37,465]
Pesticides (not specified) *[*] 5 [129,152,266,
466,467]
Polyamines, aliphatic [*] 1 [468]
Polyester (*) 2 [469,470]
Potroom aluminum smelting *[*] 10 [52,247,471-478]
Powder paints (*) 1 [479]
Pyrazolone (see reactive dye) - 1 [480]
Reactive dyes * 5 [481-485]
Refractory ceramic fibers [RCF] * 2 [486,487]
Smoke (fires, pyrolysis products) *[*] 5 [30,41,488-490]
", (oil fire and dust storm) * 1 [491]
", (biomass, indoor) (*) 1 [492]
Soldering flux (fumes) * 4 [183,493-495]
Solvents (not specified) * 4 [10,48,496,497]
Spray paint - 1 [30]
Tall oil - 1 [498]
Tear gas - 4 [499-502]
Welding fumes ** 18 [41,48,57,83,247,
281,464,503-513]
Work-site or profession Evidence level Number of studies per
work-site or profession
Ceramic production *[*] 2 [514,515]
Cleaners
Construction work (dust, agent not specified) ** 5 [8,107,136,
516,517]
Farming
", (various) *[*] 9 [119,120,144-
146,518-521]
", animals (pig, beef/veal, dairy, poultry) ** 3 [522-524]
Foundry *[*] 4 [121,147,525,526]
[see also isocyanates (MDI)]
Health care workers *[*] 4 [23,527-529]
Metallurgical industry workers * 1 [530]
Poultry confinement *(*) 4 [153,531-533]
Poultry confinement, slaughtery house * 3 [534-536]
Swine confinement ** 8 [39,40,141,155,
537-540]
World Trade Center disaster 2001 ** 8 [133,156,541-546]
[ ] down-grading due to lower quality of clinical investigations relative to the scale of the scientific level of the study.
(*) up-grading due to at least 5 cases without contradictory findings.
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tional COPD in total.
Strength and limitations
This work covers a broad range of causative agents of
irritant-induced occupational asthma or COPD. We
included various study designs.
A strength of our work is that we not only assessed
the quality of single investigations but the strength of
the body of evidence for each irritant agent.
The paradigm of “evidenced-based medicine” has been
criticized by leading scientists [547-550]. Bias in the se-
lection of information may be a problem for
generalization of findings in single studies [551,552]. In
spite of these limitations, alternative approaches to
evaluation of the literature have not been generally
accepted. Evaluation of the evidence depends on the do-
main, which means the factors to be considered in asses-
sing the extent to which the study results are reliable or
valid.
Kunz et al. [553] stressed the approach of grading sci-
entific studies on basis of additional qualified data, i.e.
dose response relationships. This latter was seen in 30/
474 individual studies in this current work. Other stud-
ies were based on evidence by OR >2 or < 0.5 for
irritant-induced OA and occupational COPD which was
applied as an approach in 40/474 individual studies (see
Additional file 3: Table S2E of online supplement
“Results”).
There are numerous procedural methods for rating
the strength of scientific evidence. The AHRQ empha-
sized in 2002: “systems for grading the strength of a
body of evidence are much less uniform than those for
rating study quality” [554].
It is possible that not all relevant studies were found
in our search of literature. Probably, some studies could
not be found by the MeSH term raster applied. Relying
solely on MeSH terms might be a problem in the identi-
fication of studies of irritant-induced OA or occupa-
tional COPD. We restricted the search to the MeSH
fields in order to increase the specificity of the search.
As for any electronic search strategy, an increase of spe-
cificity implies a decrease in sensitivity of the search.
For each single study, we took into consideration pos-
sible risks due to confounding, e.g. exposure to multiple
agents and selection bias, e.g. healthy worker effect.
Basis and quality of data
Irritant-induced obstructive airways diseases cannot usu-
ally be diagnosed in one clinical visit and, instead,
follow-up and/or detailed clinical investigations are ne-
cessary. The diagnostic “gold standard” for OA is SIC
using a specific occupational agent in an exposure
chamber. SIC is particularly indicated in the clinicalsetting where new causative substances with still un-
known adverse respiratory sensitization potential are
suspected. This “gold standard” is not applicable for
large studies; so, it was used mainly in case series or
reports.The evidence levels to confirm irritant-induced
work-relaated asthma or occupational COPD for the
listed irritant agents, professions or worksites (see Add-
itional file 3: Table S2E of online supplement “Results”)
are frequently low with the major reasons being that
high quality studies were missing and the quality of the
available studies was low. Nevertheless, this knowledge
is the best available and may help physicians to identify
a suspected irritant agent as causative in irritant-induced
work-related asthma and / or occupational COPD [555].
As also recently stressed by Quint et al. [555], “imple-
menting an evidence-based identification and regulatory
process for OA will help to ensure primary prevention
of OA”. In cases of low evidence level of an agent that
does not exclude a causative role, caution should be
exercised and a more detailed diagnostic testing of rele-
vant exposure should be performed.
Occupational COPD, an underestimated category
We identified only 20 out of 474 publications that re-
ferred to occupational COPD, with most of them impli-
cating inorganic or organic dust or fumes, such as
cement dust, construction work and diesel exhaust, as
the causative agents.
As an example, the mixed agent cement dust was investi-
gated in 14 studies but only four studies documented ce-
ment dust as the causative agent in occupational COPD
[111,418,419,422] (see Table 3 and Additional file 3: Table
S2E “Results”). The remaining 10 studies described irritant-
induced OA cases [235,423-426,530] or identified signifi-
cant asthma symptoms/ obstructive ventilation patterns
without a clear diagnosis (5 studies: [178,417,420,556]). It
can be assumed that if it had been considered on the other
10 studies then occupational COPD caused by cement dust
would have been frequently observed.
The population-attributable fraction for COPD asso-
ciated with occupational exposure has been estimated
between 9% and 31% [1,64,65]. However the true
population-attributable risk due to occupational expos-
ure is unclear [6,557] as occupational COPD is rarely
clinically diagnosed. Blanc et al. [558] recently published
an ecological analysis using data from three large stud-
ies, comprising the Burden of Obstructive Lung Disease
study [169], the Latin American Project for Investigation
of Obstructive Lung Disease (PLATINO) and the Euro-
pean Community Respiratory Health Survey follow-up
(ECHRS II), where occupational COPD was also not a
primary goal. The original publications are mainly con-
cerned with OA or asthma symptoms, but a history of
pre-existing OA or RADS cannot be allowed to exclude








Agents, work-site or profession
[Synonym] (CAS)
*** 0 -
** 17 Benzene-1, 2, 4-tricarboxylic acid-1,2-anhydride [trimellitic anhydride] (552-30-7); chlorine (7782-50-5);
cobalt (7440-48-4); various isocyanates, isocyanurate (HDI, MDI, TDI), diphenylmethane diisocyanate
[MDI] (5873-54-1), toluene diisocyanate, TDI 2,4 (584-84-9), TDI 2,6: (91-08-7); platinum salts (7440-06-4);
cement ; environmental tobacco smoke; grain ; welding fumes; construction work (dust, agent not
specified); farming, animals (pig, beef/veal, dairy, poultry); swine confinement; World Trade Center
disaster 2001
*[*] 12 Ceramic production; Phthalic anhydride (85-44-9); glutaraldehyde [glutaral] (11-30-8); sulfur dioxide
(7446-09-5); cotton (dust, raw) CNT 750; potroom aluminum smelting; farming (various); foundry;
smoke (fires, pyrolysis products); pesticides (not specified); cleaning agents (not specified); health
care workers
* 39 Acetic acid (64-19-7); sulfuric acid (7664-93-9); metacrylates, loctideW (53858-53-0); aluminum salts
[aluminum fluoride] (7724-18-1); aluminum sulfate: (10043-01-3); ammonia (7664-41-7); various
anhydrides; tetrachlorophthalic anhydride (117-08-8); azobisformamide (123-77-3); cadmium (fumes)
(7440-43-9); carbon black dust (1333-86-4); ethylenediamine (107-15-3); formaldehyde (gas, dust)
(50-00-0); hexamethylenetetramine (100-97-0); methyl isocyanate [MIC] (624-83-9); naphthylene
diisocyanate (3173-72-6); polymethylene polyphenyl isocyanate (9016-87-9); N-methylmorpholine
(09-02-4); ozone (gassings) (10028-15-6); paraquat (4685-14-7); diammonium peroxodisulfate (
7727-54-0); phenylglycine acid chloride (39478-47-2); piperazine dihydrochloride (142-64-3); polyvinyl
chloride (fume) (9002-86-2); rosin core solder; thermal decomposition (8050-09-7); vanadium
(7440-62-2) + divanadium pentoxide (1314-62-1); cleaning agents (not specified); green coffee ;
diesel exhaust; endotoxin; oil (spill); paint (fumes); pesticides (not specified); reactive dyes; refractory
ceramic fibers [RCF]; smoke (fires, pyrolysis products; oil fire and dust storm); soldering flux; solvents
(not specified); health care workers; poultry confinement; slaughtery house; metallurgical industry
workers
[*] 3 Nitrogen chloride (10025-85-1); polyamines, aliphatic; potassium persulfate (7727-21-1) and ammonium
peroxydisufate (7727-54-0); grain rice
(*) 29 Acids not specified; hydrochloric acids (7647-01-0); alkyl cyanoacrylates; 3-amino-5-mercapto-1,2,4-triazole
l(16691-43-3); aziridine, polyfunctional (64265-57-2); chloramine T (powder dust) (7080-50-4); chromate
(not specified); 3-(diamino-amino)propylamine (109-55-7); dichlorodiethyl sulfide (505-60-2);
2-diethylaminoethanol (100-37-8); diinitrogen tetraoxide (10544-72-6); hexamethylene diisocyanate
[HDI], plus isodurane diisocyanate (822-06-0); HDI biuret plus (4035-89-6); nickel sulphate anhydrous
(7786-81-4); hexahydrate (10101-97-0); paraphenylenediamine (106-50-3); persulfate (not specified);
polypropylene, heated to 250 °C (9003-07-0); potassium dichromate (7778-50-9); potassium aluminum
tetrafluoride (14484-69-6); sodium iso-nonanoyl oxybenzene sulphonate [SINOS] (123354-92-7); sodium
metabisulfite (7681-57-4); styrene monomer (100-42-5); chlorofluorocarbons (degradation products);
hairdressing chemicals; lubricants (not specified); paper dust A111; aliphatic polyamines; polyester;
powder paints; smoke (biomass, indoor)
- 93 Acids various; dodecanedioic (693-23-2-1); hydrofluoric acids (7664-39-3); cyanoacrylate glue; methyl
2-cyanoacrylate (137-05-3); methylmethacrylate (80-62-6); 2-aminoethanol (141-43-5); amino-ethyl-
ethanolamine (111-41-1); ammonium chloride (triple salt) (12125-02-9); ammonium thioglycolate
(5421-46-5); amprolium hydrochloride (137-88-2); dioctyl phthalate (117-81-7); hexahydrophthalic
anhydrides (37226-48-5); himic anhydrides (2746-19-2); maleic anhydrides (108-31-6);
methyltetrahydrophthalic anhydrides (26590-20-9); pyromellitic dianhydride (89-32-7); benzalkonium
chloride (fumes) (8001-54-5); 1, 2-benzisothiazoline-3-one (fumes) (2634-33-5); bisulfite, SO2:(7446-09-5);
hydrobromic acid bromine; bromochlorodifluoromethane [halon 1211] (353-59-3); bromotrifluoromethane
[halon 1301](75-63-8); calcium carbonate [chalk powder]; calcium oxide (1305-78-8); captafol (2425-06-1);
chlorhexidine (55-56-1); aliphatic + cycloaliphatic diamine, (hardener) (2855-13-2) [isophorone diamine];
diazonium tetrafluoroborate (14239-22-6); dichlorvos [organophosphate] (62-73-7); diethanolamine
(111-42-2); 2-dimethylaminoethanol [dimethyl ethanolamine] (108-01-0); ethylene oxide (75-21-8);
freon-22; hexachlorophene (70-30-4); hydrazine (302-01-2); iridium salt; isocyanate prepolymers;
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate (4098-71-9); triglycidil isocyanurate (2451-62-1);
triphenylmethane triisocyanate; isothiazolinone (55965-84-9); lauryl dimethyl benzyl ammonium chloride
(139-07-1); metam sodium (144-54-7); methylmercaptan (74-93-1); monoethanolamine (141-43-5);
ninhydrin (485-47-2); palladium (7440-05-3); ammonium persulfate; alcalic persulfate; sodium persulfate
(7775-27-1); dipotassium peroxo-peroxodisulfate (7727-21-1); phosgene (75-44-5); polyethylene
(9002-88-4); polymethyl-methacrylate (9011-14-7); sodium azide (powder dust) (26628-22-8); sulfathiazole
(2-14-0); terpene (3-carene) (3466-78-9); tetrahydrothiophene (110-01-0); tetrachloroisophthalonitrile
(fungicide); tetramethrin (7696-12-0); tributyl tin oxide; triethanolamine (102-71-6); tungsten carbide
(11130-73-7); turpentine (8006-64-2); tylosin tartrate; uranium hexafluoride (7783-81-5); urea (fume)
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Table 4 Strength of evidence for agents, professions and work-site according to the modified RCGP three-star
system [88] (Continued)
(57-13-6); urea formaldehyde foam (64869-57-4); phenol-formaldehyde resin (9003-35-4); zinc (fume)
(7440-66-6); zinc chloride (fume) (7646-85-7); acid fluxes; acrylic acid; airbag content; bleaching agent
(fumes); chlorofluorocarbons (degradation products); detergents; cutting oil; ECG ink; floor sealant
(aromatic hydrocarbons); fumigating agent; furan-based binder; metal coating remover (coating
removing chemical); metal oxide (fume); metal working fluids; perfume agents (research lab);
pyrazolone; spray paint; tall oil; tear gas
CAS =Chemical abstracts service.
RCGP = Royal College of General Practitioners.
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the contribution of occupational exposure cannot be
ignored, because “the association between adverse work-
ing conditions and COPD (. . .) carries significance as a
global finding (. . .), alongside the (. . .) critical contribu-
tion of cigarette smoking to disease prevalence”.
General acceptance of this statement does not exist
[66,559], although evidence for an association between
individual exposure levels and COPD is accumulating in
the latest literature [1,6,106,506,557,560,561].
Irritant-induced WRA – a broader definition
Irritant-induced OA includes three subcategories that
predominantly differ according to the concentration of
irritants in the workplace atmosphere. It can occur with-
out a latency period, such as RADS, as was shown for 46
causative agents in our study, with the highest preva-
lence after spills of acids or tear gas (see Additional file
3: Table S2E of online supplement“Results”). Other
agents, e.g. isocyanates or welding fumes, usually induce
a slower onset of low dose irritant-induced asthma with
a latency period and mostly without evidence of an IgE-
mediated pathomechanism.
The ACCP also stated in its last Consensus Statement
in 2008 [24] that cases who do not meet the stringent cri-
teria of RADS [30] (e.g. where there is a lag of several days
before the onset of symptoms or where there is no single
massive exposure but rather repeated exposure over days
and weeks) should be subsumed into a broader category
of irritant-induced OA. As outlined in the section “Intro-
duction” Brooks et al. [31] and later also others, e.g. Burge
[27] suggested using the term “not so sudden onset of
irritant-induced asthma” for those developing the disorder
after such exposure within a period of 2 days to 4 months.
In an extended definition corresponding to ours, Burge
[27] he used the term “low dose irritant-induced OA” for
those developing the disorder after relatively low repeated
exposure for more than 4 months.
Bardana [562] and Vandenplas and Malo [563] ques-
tioned whether such rather low concentrations could ac-
tually cause irritant-induced OA. These different
opinions about the pathogenetic role of chronic or re-
current exposure(s) to low concentrations of respiratory
irritants seem to be due to inadequate considering ofthe increased susceptibility of a small group of workers.
Occupational disease statistics do mostly neither contain
such cases nor work-aggravated asthma cases so far.
Another critical issue is the frequent disregarding of
work-aggravated asthma due to occupational agents by
physicians.
Comparison to occupational guidelines or consensus
statements – what is new?
In the current analysis, the focus has been on irritant
agents causing irritant-induced occupational asthma and
COPD. Both entities have been underestimated or even
overlooked in the past. Occupational COPD has not
been considered as a subgroup of COPD thus so far
[559,564]; and the definition of irritant-induced OA has
been heterogenous at best [24,552,565,566]. Further-
more, the guidelines dealing with respiratory disorders
have not even considered causation by individual irritant
agents, so far.
The ACCP published a Consensus Statement in 2008
[24] which focuses on the diagnosis and management of
WRA after a latency period, i.e. due allergens and “sensi-
tizers” with unknown pathomechanisms, effectively side-
lining irritant-induced OA to RADS.
The Agency for Healthcare Research and Quality
(AHRQ) in its the Evidence Report “Diagnosis and
Management of WRA” [552] addressed the key question
of the best diagnostic approach for a patient with sus-
pected WRA. In respect of irritant-induced OA, they
only considered RADS as a non-allergic asthma due to
mainly low molecular weight compounds of unknown
pathomechanism.
The Canadian Thoracic Society “Guidelines for OA”
[567] was the first evidence-based guideline, although
irritant-induced OA was limited to RADS. If criteria
were not fulfilled then irritant-induced OA was dis-
cussed as a controversial diagnosis. The three evidence
levels in the “Guidelines for OA” were based on quality
of scientific evidence within analyzed studies [568].
Compared with the modified RCGP three-star grading
(see Additional file 2: Table S2D in online supplement
“Methodology”), the different levels are defined in a
more general way, i.e. not considering the quantitative
aspect if only studies with lower scientific evidence exist.
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the BOHRF [3,569] were designed to improve the pre-
vention, identification and management of OA. This
work mainly deals with asthma after a latency period
and considers irritant-induced OA and RADS to be
closely related entities. The difference in comparison
with our analysis is obvious even though our evidence-
based approach was closely related to the BOHRF guide-
lines and used the same grading systems.
In summary, the existing guidelines or statements
mostly define irritant-induced OA as RADS. Work-
aggravated asthma, and occupational COPD as a distinct
entity, have not been considered in any guideline, al-
though the latter is becoming recognized as such in
more recent publications [557,559,564].
This evidence-based approach is the first which fo-
cuses on especially irritative agents within the broader
definition of irritant-induced OA and occupational
COPD. For clarification, the grading systems were modi-
fied in accordance with BOHRF [3] when considering
the extent and quality of the clinical investigations, with
the goal of creating evidence levels for causative irrita-
tive agents as precisely as possible.
Concluding remarks
OA is the most common chronic occupational lung dis-
ease in many industrialized countries [3]. COPD is the
fourth leading cause of death worldwide with a signifi-
cant portion of occupational cases [66]. The term occu-
pational COPD does not officially exist. However, it has
to be considered as a subcategory of COPD [559].
Our study shows that reliable, sensitive and specific
methods are required in the diagnostic approach
for confirming irritant-induced OA, work-aggravated
asthma, or occupational COPD. The specific diagnostic
work-up in a subject with such a suspected disorder
depends on the individual clinical data and on the know-
ledge of asthma- or COPD-inducing agents in the work-
place. On this basis, our review may help in diagnostics
especially for agent exposures where we were able to re-
late irritant-induced work-related asthma or occupa-
tional COPD to a high evidence-based level (i.e. two
stars according to the RCGP grading).
We have created a list representing the strength of evi-
dence for irritating agents to be causative in irritant-
induced work-related asthma or occupational COPD (see
Additional file 3: Table S2E of online supplement
“Results”).
A low level or absence of evidence for many agents
in causing irritant-induced work-related asthma or occu-
pational COPD is sometimes due to contradictory find-
ings in literature, but is mostly due to the absence
of rigorous scientific studies, with many gaps remaining
in the knowledge of a causative role for individualagents and conditions. Therefore, and because of rarely
applied diagnostic approach in the clinical setting, our
literature search and evaluation lead us to assume that
irritant-induced respiratory disorders are considerably
underreported in cross-sectional studies and occupa-
tional disease statistics.
Our list needs updating in the light of recent literature,
in order to provide a realistic overview of agents and evi-
dence level in their causation of irritant-induced work-
related or occupational COPD.
The estimated high population-attributable risk in the
range of 5–25% for occupational asthma and COPD from
occupational exposure, indicates that more detailed and in-
tensive research, as well as strategies designed to prevent
these disorders, should receive high priority in the global
efforts to reduce the burden of these diseases. This implies
extended evidence-based diagnostic procedures that help to
optimize primary and secondary prevention by the physi-
cians dealing with occupational diseases.
Reduction of the exposure to noxious agents by lower-
ing the permissible exposure limits is the best and
favoured way for intervention. If this is not possible
then other effective primary preventive measures, such
as wearing adequate respiratory devices, are required
[28,570-574].
Finally, we would like to mention that the diagnosis of
irritant-induced OA should be considered if:
– there has been exposure to high concentration of an
irritative agent identified in this study and the
development of asthma without a latency period
(original definition of RADS) or
– there has been chronic or repeated exposures to
moderate (in the TLV ranges) concentrations
of an irritative agent identified in this review
and the development of asthma with a latency
period, but without evidence of an IgE-mediated
pathomechanism and
– there is evidence that a highly susceptible
subject (e.g. with pre-existing NSBHR) develops new
onset asthma upon occupational exposure to an
identified irritative agent even at concentrations
below the TLV.
Work-aggravated asthma should be considered if:
– there have been any of the before-mentioned
exposures and
– there is a temporally related significant worsening of
a pre-existing asthma or of a concomitant non-
occupational asthma.
The diagnosis of occupational COPD should be con-
sidered if:
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causing occupational COPD, and
– not reversible chronic airway disease is
demonstrated and
– there is a temporal relationship between the period
of exposure (mostly cumulative exposures to
identified irritants ) and the development of COPD
(acute WRA symptoms are frequently
missing).
Occupational COPD has to be taken into consider-
ation especially in non-smokers, i.e. when dominating
non-occupational causes for COPD are obviously not
present.
Endnotes
aEpidemiologic study design which is generally
applied to test one or more specific hypotheses, typically
whether an exposure is a risk factor for a disease [575].
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